InsidersTradesSigma
Track the 20/20 Biolabs, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). The latest transaction was disclosed on 23 February 2026 (C). Among the most active insiders: Rollins John Woodson. Every trade is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 February 2026
Declarations4 total
13,029 shares0Common StockSEC:0001213900-26-019456:0
31 shares0Common StockSEC:0001213900-26-019424:0
7,669 shares0Common StockSEC:0001213900-26-019423:0
7,700 shares0Common StockSEC:0001213900-26-019421:0
4 of 4 declarations
About 20/20 Biolabs, Inc.
20/20 Biolabs, Inc. is a biotechnology company focused on developing innovative solutions for research and medical applications. It is listed on the XNAS market.